Literature DB >> 20060357

Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma.

F P Koch1, P W Kämmerer, P Kämmerer, B Al-Nawas, J Brieger.   

Abstract

Glutathione S-transferases (GST) are antioxidant enzymes and oxidative stress markers in oral carcinogenesis. They present a system of polymorphic proteins. Some variants are associated with increased sensitivity to toxic compounds, as it is known for the GSTM1-null variant allele. However, the influence of the GSTM1 allele variant genotype on GSTM1-mRNA quantity in oral squamous cell carcinoma (OSCC) and normal mucosa as well as the impact on prognosis remains unclear. The genotype for GSTM1 (mutation vs. wild type) was determined by polymerase chain reaction (PCR) using genomic DNA extracted from peripheral blood from 28 OSCC patients. From the same patients, 28 pairs of OSCC cells and normal oral mucosal cells were obtained by brush biopsy. mRNA was extracted from these paired samples and the expression levels of GSTM1 were examined by real-time reverse transcriptase qPCR (RT-qPCR). The mRNA expression of the OSCC samples was normalized against an external standard, as well as to the corresponding normal mucosa. The coincidence of GSTM1 genotype and GSTM1-mRNA-expression level was examined. In 15 patients (54%), the null genotype GSTM1 was present. In the GSTM1-null allele group, the GSTM1 gene expression level was determined at 1.63 (mean: 3.08; SD 3.4) folds vs. 3.6 (mean: 10.5; SD 14.2) folds in the group with the positive genotype (p=0.06), if calibrated vs. individual normal mucosa. More T3 and T4 OSCCs (+38%), higher UICC stadia (+38%) and more lymphatic metastasis (+28%) were seen in the group with the negative allele. Furthermore, positive GSTM1 genotype and enhanced GSTM1 gene expression was accompanied with increased tumor size, lymphatic metastasis status and UICC stadium. A coincidence of null type GSTM1 and lowered GSTM1 gene expression was observed. The larger tumors and more frequent lymph node metastases in this group could be explained by the insufficient cell protection by GST.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060357     DOI: 10.1016/j.oraloncology.2009.11.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  4 in total

1.  The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer.

Authors:  Maximilian Krüger; Andreas Max Pabst; Benjamin Mahmoodi; Burkhard Becker; Peer Wolfgang Kämmerer; Felix Peter Koch
Journal:  Clin Oral Investig       Date:  2015-01-18       Impact factor: 3.573

Review 2.  Association between -308G/A TNFA Polymorphism and Susceptibility to Type 2 Diabetes Mellitus: A Systematic Review.

Authors:  Geisa Izetti Luna; Izabel Cristina Rodrigues da Silva; Mauro Niskier Sanchez
Journal:  J Diabetes Res       Date:  2016-10-16       Impact factor: 4.011

3.  MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

Authors:  Tessho Maruyama; Kazuhide Nishihara; Masato Umikawa; Akira Arasaki; Toshiyuki Nakasone; Fumikazu Nimura; Akira Matayoshi; Kimiko Takei; Saori Nakachi; Ken-Ichi Kariya; Naoki Yoshimi
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  Association of Glutathione-S-Transferases M1 and T1 Deletional Variants with Development of Oral Squamous Cell Carcinoma: A Study in the South-East of Iran.

Authors:  Shirin Saravani; Masoud Miri-Moghaddam; Ali Bazi; Ebrahim Miri-Moghaddam
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.